IHS Chemical Week

Chemical Week Magazine :: Pharmaceuticals & Fine Chemicals

Sanofi-Aventis Signs Deal with ThalesNano

10:32 AM MDT | June 2, 2008 | Deepti Ramesh

ThalesNano Inc. (Budapest), a developer of micro-scale flow instruments for chemistry, says it has signed an R&D agreement with Sanofi-Aventis (Paris) that will focus on continuous process chemistry technologies to reduce drug realization time. The collaboration will study the use and application of ThalesNano’s continuous process chemistry technologies within the Sanofi-Aventis drug R&D process, from discovery to active pharmaceutical ingredients (API) production. “The ThalesNano continuous process technology is already well-established in...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers




contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa